<P><FONT size=5>中银国际-医药行业更新报告-</FONT></P>
<P><FONT size=5>16 March 2007 (Friday) 2页英文</FONT></P>
<P><FONT size=5> </FONT></P>
<P><FONT size=5></FONT></P>
<P><FONT size=5>SFDA revises medicine registration management rules.<BR>On 10 March 2007, the State Food and Drug Administration (SFDA)<BR>issued on its website a draft report on medicine registration<BR>management rules to seek opinions over the next two months. The<BR>medicine registration management rules define new medicines and<BR>the rights of their owners. It also gives a guidance on how to obtain<BR>certifications for drugs and ways to meet other necessary requirements.<BR>The draft looks into ways to prevent the government from abusing its<BR>powers. It also defines new drugs (those that have never been sold in<BR>the country). Under the draft regulation, medicines in fresh packages<BR>and of new specifications will not be deemed to be new products</FONT></P>